🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#EACVI2025 abstract submission deadline has been extended! There’s more time to share your imaging work in echo, CMR, nuclear cardiology & CT. Be published. Reach a global audience. Connect with leaders. 📅 Deadlines: abstracts - 3 June / clinical cases - 10 June

Dr Panithaya Chareonthaitawee MD at Congreso Nacional de Cardiología FAC Argentina 🌟How recent nuclear cardiology research studies are impacting the value proposition off #CVNuc #CNC2025 #Cardiología #CongresoFAC

Dr Marcelo Di Carli at Congreso Nacional de Cardiología FAC Argentina 🌟 Enfermedad microvascular: ¿cuánto podemos saber y hacer? / Microvascular disease: How much can we know and do?#CVNuc #CNC2025 #CongresoFAC #FACMendoza #FAC

📢 Take part in our survey gathering information on the variability of CT acquisition protocols used in PET/CT and SPECT/CT imaging across different international medical centres ⏰ Participate before June 23! 🔗 committeemeeting.questionpro.com/t/AKfvuZ6GAa

Great 2nd day at the #EACVI National Society Summit today in Valencia 🇪🇸, where we’re engaging with national cardiac societies and hearing their innovative pitches for the future of #CVImaging. These bold ideas and collaborative efforts reflect the shared vision we all have—to

Honored to be here in Mendoza, Argentina, to represent ASNC Society. We are working together to strengthen partnerships across the globe to advance education, research, and access in Nuclear Cardiology. #CVNuc #ASNC

New #CVNuc #ThinkPET case poll: 27-year-old female with history of childhood murmurs has the following coronary CTA. What would the corresponding vasodilator PET blood flow (MBF) most likely demonstrate? Vote below.

Vote: What would the corresponding vasodilator PET blood flow (MBF) most likely demonstrate? Watch for the case in ASNC Society Cardiac PET Resource Center: shorturl.at/wDOwB

The Comparison of Quantitative Evaluation Results of the MPS SPECT/CT and Coronary Angiography: Determining the Most Valuable Quantitative Evaluation Score You can see the free full text of the research by Nazlı Pınar Karahan Şen et al. Link : mirt.tsnmjournals.org/articles/the-c…

FDA approval of 18F-flurpiridaz for PET: Stepping into a new era of myocardial perfusion imaging? ow.ly/RZab50VKLtE #MolecularImaging #NuclearMedicine #CoronaryArteryDisease Thomas H Schindler WashUMedMIR Ronald G. Schwartz Marcelo Di Carli Venk Murthy MD PhD Sharmila Dorbala

Excited to have participated in this #Delphi study for the management of 🫀#sarcoidosis, just published in JACC Journals. Covers lots of controversial topics in #sarcoid management. sciencedirect.com/science/articl…

Is PYP ready for prime time for generalized screening for cardiac amyloidosis? An interesting debate of Pro Vs Con and overall perspective journalofnuclearcardiology.org/article/S1071-… Mallika Lal Ahmad Masri Adam Ioannou marianna fontana mathew.maurer Journal of Nuclear Cardiology

Now live: ASNC's congressional briefing on How Prior Authorization is Harming Patient Care & Contributing to Physician Burnout is underway at the Russell Senate Building. Presenters include Drs. Winchester, Phillips, Chareonthaitawee, Keating, Mr. Neil Patil, Patrick Rucker &

At today’s Prior Authorization Briefing on Capitol Hill, ASNC President Panithaya Chareonthaitawee MD addressed a packed room, emphasizing the importance of early, accurate diagnosis and the critical role of nuclear cardiology. #cvnuc #HealthPolicy #FixPriorAuth Kathy Flood

At today's congressional briefing, experts highlighted how #priorauth practices often disrupt patient care, introduce inefficiencies, & burden clinicians. Moderated by ASNC Immediate Past President Lawrence Phillips, the discussion called for reforms that reflect evidence-based

On Tuesday June 10, 2025, from 5:30 to 7:30 PM ET for part 2 of the “Think Amyloid! Cardiac Amyloidosis for Community Cardiologists” series. State of the Art Treatment in ATTR-CM will focus on current, evidence-based treatment strategies for ATTR-CM, including evolving

ICYMI ... NEW PODCAST EPISODE HAS DROPPED! youtu.be/FmY3HwRyfXM?si… In today’s episode we’ll be talking about genetic counseling for those impacted by hereditary amyloidosis. This topic is important for patients who have one of the more than 130 types of genetic variants of

Advances in the screening, diagnosis, and treatment of transthyretin amyloid cardiomyopathy: New insights and future directions Latest review article with my colleagues Drs. Andrew Girard and Talal Asif pubmed.ncbi.nlm.nih.gov/40147532/

2024 SNMMI Highlights Lecture: Cardiovascular Sciences. ow.ly/Ja2150VKLT2 #NuclearMedicine #Cardiology #MedicalImaging #SNMMI24